- Home
- LSCC vs AXSM Comparison
LSCC vs AXSM Comparison
Compare LSCC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSCC | AXSM |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.0B |
| IPO Year | 1989 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LSCC | AXSM |
|---|---|---|
| Price | $82.29 | $185.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 20 |
| Target Price | $82.18 | ★ $197.95 |
| AVG Volume (30 Days) | ★ 1.9M | 706.1K |
| Earning Date | 02-10-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $494,889,000.00 | ★ $561,263,000.00 |
| Revenue This Year | $4.26 | $67.77 |
| Revenue Next Year | $21.54 | $58.56 |
| P/E Ratio | $410.62 | ★ N/A |
| Revenue Growth | N/A | ★ 65.83 |
| 52 Week Low | $34.69 | $86.99 |
| 52 Week High | $89.92 | $191.50 |
Technical Indicators
Market Signals| Indicator | LSCC | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 62.90 |
| Support Level | $79.10 | $180.56 |
| Resistance Level | $88.50 | $190.76 |
| Average True Range (ATR) | 4.14 | 5.40 |
| MACD | -0.71 | -0.79 |
| Stochastic Oscillator | 32.06 | 70.10 |
Price Performance
Historical ComparisonAbout LSCC Lattice Semiconductor Corporation
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.